140 related articles for article (PubMed ID: 9129144)
1. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.
Avigad S; Barel D; Blau O; Malka A; Zoldan M; Mor C; Fogel M; Cohen IJ; Stark B; Goshen Y; Stein J; Zaizov R
Oncogene; 1997 Apr; 14(13):1541-5. PubMed ID: 9129144
[TBL] [Abstract][Full Text] [Related]
2. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
[TBL] [Abstract][Full Text] [Related]
3. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
Warneford SG; Witton LJ; Townsend ML; Rowe PB; Reddel RR; Dalla-Pozza L; Symonds G
Cell Growth Differ; 1992 Nov; 3(11):839-46. PubMed ID: 1467311
[TBL] [Abstract][Full Text] [Related]
4. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
[TBL] [Abstract][Full Text] [Related]
5. A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.
Felix CA; Strauss EA; D'Amico D; Tsokos M; Winter S; Mitsudomi T; Nau MM; Brown DL; Leahey AM; Horowitz ME
Oncogene; 1993 May; 8(5):1203-10. PubMed ID: 8479743
[TBL] [Abstract][Full Text] [Related]
6. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
8. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
Kovar H; Auinger A; Jug G; Müller T; Pillwein K
Oncogene; 1992 Nov; 7(11):2169-73. PubMed ID: 1359493
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
[TBL] [Abstract][Full Text] [Related]
10. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
11. Screening for germline p53 mutations in pediatric and adult patients of high-risk groups in Poland.
Fiszer-Maliszewska L; Czernik J; Sawicz-Birkowska K; Perek D; Kozera M; Wojciechowska B; Kazanowska B; Hudziec P; Kilar E
Arch Immunol Ther Exp (Warsz); 2000; 48(4):309-15. PubMed ID: 11059649
[TBL] [Abstract][Full Text] [Related]
12. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
[TBL] [Abstract][Full Text] [Related]
13. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
14. Absence of significant germ line p53 mutations in ovarian cancer patients.
Buller RE; Skilling JS; Kaliszewski S; Niemann T; Anderson B
Gynecol Oncol; 1995 Sep; 58(3):368-74. PubMed ID: 7672703
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
[TBL] [Abstract][Full Text] [Related]
16. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
Law JC; Strong LC; Chidambaram A; Ferrell RE
Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
Bendig I; Mohr N; Kramer F; Weber BH
Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
[TBL] [Abstract][Full Text] [Related]
18. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
19. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 mutations with metastatic prostate cancer.
Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
